Latest filing published 13 Jun 2022 for Khiron Life Sciences Corp..
No signal scores available.
Swapan Kakumanu appears in our data through filings on Khiron Life Sciences Corp. shares, published by SEDI. In total, 3 filings cover trades dated from 1 October 2021 to 10 June 2022.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 13 June 2022, reports a transaction in Khiron Life Sciences Corp. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations